Inc. ("bluebird bio") today announced it has reached an agreement with the Center for Medicare and Medicaid Innovation to offer an outcomes-based agreement for LYFGENIA gene therapy under the Cell and ...
AMSTERDAM, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Weaviate ’s latest SaaS service is bringing freedom and flexibility to a crucial area of AI development: data vectorization. Launched today, Weaviate ...